Exagen Statistics
Share Statistics
Exagen has 17.64M shares outstanding. The number of shares has increased by 2% in one year.
| Shares Outstanding | 17.64M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.07% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 8.62M |
| Failed to Deliver (FTD) Shares | 6.42K |
| FTD / Avg. Volume | 9.79% |
Short Selling Information
The latest short interest is 52.21K, so 0.3% of the outstanding shares have been sold short.
| Short Interest | 52.21K |
| Short % of Shares Out | 0.3% |
| Short % of Float | 0.63% |
| Short Ratio (days to cover) | 3.12 |
Valuation Ratios
The PE ratio is -1.49 and the forward PE ratio is -3.55.
| PE Ratio | -1.49 |
| Forward PE | -3.55 |
| PS Ratio | 0.67 |
| Forward PS | 1.6 |
| PB Ratio | 1.55 |
| P/FCF Ratio | -2.3 |
| PEG Ratio | n/a |
Enterprise Valuation
Exagen Inc. has an Enterprise Value (EV) of 58.90M.
| EV / Earnings | -2.49 |
| EV / Sales | 1.12 |
| EV / EBITDA | -3.08 |
| EV / EBIT | -2.58 |
| EV / FCF | -3.85 |
Financial Position
The company has a current ratio of 4.02, with a Debt / Equity ratio of 0.86.
| Current Ratio | 4.02 |
| Quick Ratio | 3.78 |
| Debt / Equity | 0.86 |
| Total Debt / Capitalization | 46.21 |
| Cash Flow / Debt | -0.74 |
| Interest Coverage | -9.78 |
Financial Efficiency
Return on equity (ROE) is -1.04% and return on capital (ROIC) is -49.27%.
| Return on Equity (ROE) | -1.04% |
| Return on Assets (ROA) | -0.42% |
| Return on Capital (ROIC) | -49.27% |
| Revenue Per Employee | 302.00K |
| Profits Per Employee | -136.14K |
| Employee Count | 174 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 8.04 |
Taxes
| Income Tax | 33.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 274.19% in the last 52 weeks. The beta is 1.35, so Exagen 's price volatility has been higher than the market average.
| Beta | 1.35 |
| 52-Week Price Change | 274.19% |
| 50-Day Moving Average | 3.28 |
| 200-Day Moving Average | 2.4 |
| Relative Strength Index (RSI) | 76.76 |
| Average Volume (20 Days) | 65.55K |
Income Statement
In the last 12 months, Exagen had revenue of $52.55M and earned -$23.69M in profits. Earnings per share was $-1.34.
| Revenue | 52.55M |
| Gross Profit | 29.46M |
| Operating Income | -22.84M |
| Net Income | -23.69M |
| EBITDA | -19.15M |
| EBIT | -22.84M |
| Earnings Per Share (EPS) | -1.34 |
Balance Sheet
The company has $36.49M in cash and $23.72M in debt, giving a net cash position of $12.77M.
| Cash & Cash Equivalents | 36.49M |
| Total Debt | 23.72M |
| Net Cash | 12.77M |
| Retained Earnings | -279.22M |
| Total Assets | 43.60M |
| Working Capital | 26.78M |
Cash Flow
In the last 12 months, operating cash flow was -$14.46M and capital expenditures -$828.00K, giving a free cash flow of -$15.29M.
| Operating Cash Flow | -14.46M |
| Capital Expenditures | -828.00K |
| Free Cash Flow | -15.29M |
| FCF Per Share | -0.86 |
Margins
Gross margin is 56.06%, with operating and profit margins of -43.46% and -45.08%.
| Gross Margin | 56.06% |
| Operating Margin | -43.46% |
| Pretax Margin | -45.02% |
| Profit Margin | -45.08% |
| EBITDA Margin | -36.45% |
| EBIT Margin | -43.46% |
| FCF Margin | -29.1% |
Dividends & Yields
XGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -23.1% |
| FCF Yield | -14.95% |
Analyst Forecast
The average price target for XGN is $7, which is 20.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $7 |
| Price Target Difference | 20.7% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Scores
| Altman Z-Score | -6.45 |
| Piotroski F-Score | 2 |